Tom Castles


Menopausal Hormone Therapy with Estrogen Alone Decreases Breast Cancer Incidence

December 14, 2019

Women who took estrogen alone as hormone therapy for their menopause experienced decreased rates of breast cancer and death from the disease even after they stopped taking the therapy, when compared to women who took estrogen with progestin.

Addition of Perjeta to Standard Care Improves Survival in HER2-Positive Early Breast Cancer

December 12, 2019

Researchers found that the addition of Perjeta to Herceptin plus chemotherapy reduced the relative risk for breast cancer recurrence or death in patients with operable HER2-positive early breast cancer, according to a six-year follow-up.